American Association of Clinical Endocrinology (AACE)

A survey of AACE members in the United States showed that levothyroxine is the preferred agent prescribed for hypothyroidism, as with similar studies conducted by the Treatment of Hypothyroidism in Europe by Specialists collaborative. Read more: https://lnkd.in/gVC72JmV

These findings highlight the potential role of approved pharmacologic therapies for obesity, particularly liraglutide and naltrexone/bupropion, as treatment options for individuals with both obesity and binge eating, underscoring the need for standardized outcomes and further trials to guide clinical practice. Read more: https://lnkd.in/gWH2Vren

Register for our free webinar series- The Metabolic Paradox: Understanding the Interplay Between Obesity and MASLD/MASH. Learn about the latest treatment guidelines and algorithms, emerging pharmacotherapies, and evidence-based approaches.

Our webinar, Transforming Patient Care with the Obesity Algorithm: Practical Insights is now available as a complimentary on-demand webinar designed to equip health care professionals with practical, evidence-based strategies for the effective management of obesity as a serious, progressive chronic disease. Explore the importance of proactive screening, accurate staging, and long-term treatment to prevent complications and address obesity-related comorbidities. Register today: https://lnkd.in/guer7xAE.

Are you prepared to manage your diabetes in an emergency? While emergency situations are stressful and challenging for anyone, they can be potentially life-threatening to a person with a chronic medical disease such as diabetes. Our Diabetes Emergency Plan is a convenient checklist that contains all of the essential items those with diabetes need to have readily available in the event of an emergency: https://lnkd.in/eRjcuYDh.

This meta-analysis offers evidence that dipeptidyl peptidase-4 inhibitor, glucagon-like peptide-1 receptor agonists, and sodium-glucose cotransporter-2 inhibitor are not associated with a higher risk of clinically detected bladder cancer, although the findings rely on passive reporting. Read more: https://lnkd.in/gsPM7zRH

If your blood sugar is on the rise, it’s not just a diabetes risk. AACE President Dace L. Trence, MD, MACE, emphasizes that prediabetes can raise cardiovascular risk by driving inflammation and oxidative stress that damage blood vessels, and that bringing blood sugar down is linked with better cardiovascular outcomes. Learn more by reading the full article on Everyday Health: https://lnkd.in/g93gZdWE

Honored to speak at AACE 2026 in Las Vegas American Association of Clinical Endocrinology (AACE) #AACE2026 #WeareAACE

Excited to share that I’ll be speaking at AACE 2026 on adrenal disorders—covering the latest in diagnosis, management, and emerging therapies. Join us and be part of the conversation shaping the future of endocrinology. #AACE2026 #Endocrinology #AdrenalDisorders #WeAreAACE

The American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Management of Adults with Type 2 Diabetes - 2026 Update provides evidence-based visual guidance and key considerations for the diagnosis and management of adults with prediabetes and diabetes. Learn about the key updates from Task Force Chair Susan Samson, MD, PhD, FRCPE, FACE, and Vice Chair Priyathama Vellanki, MD, in an article with Endocrinology Advisor here: https://lnkd.in/gAjF8dB4